Personal care products
Acquired Australian company Care Pharmaceuticals in 2013 and CB Fleet in 2017.
Company Assessment
(Last updated Sep 2025)
Praise
Criticism
Information
Prestige Consumer Healthcare Inc
Praise
Criticism
Information
High ESG Risk
Sustainalytics, a top ESG research firm, evaluates environmental, social, and governance risks for over 16,000 companies. Its ESG Risk Rating reflects how much risk a company faces in its industry and how well it manages those risks. The final score includes both unmanaged and unmanageable risks, and companies are rated on a scale from negligible (0-10) to severe (40+). This company received an ESG Risk Rating of 33, placing it in the "high risk" category (retrieved April 2025).
Source: Sustainalytics
(2025)
CEO Pay Ratio of 69:1
In 2024 the median pay for a worker at this company was US$82,936. The CEO was paid 69 times this amount. Exorbitant CEO pay is a major contributor to rising inequality. CEOs are getting more because of their power to set pay, not because they are increasing productivity or possess specific, high-demand skills. The economy would suffer no harm if CEOs were paid less (or taxed more). In contrast, the CEO-to-typical-worker compensation ratio was 20-to-1 in 1965 and 58-to-1 in 1989.
Source: AFL-CIO
(2024)
CSR claims
This company has Corporate Social Responsibility claims on its website.
Source: company website
(2020)
Company Details
Type:
Public company
Founded:
1996
Revenue:
1 billion USD
(2022)
Employees:
535
(2022)
Subsidiaries:
Care Pharmaceuticals Pty Ltd
Healthcare products
Established in Australia in 1986 and acquired by Prestige Brands in 2013.
Contact Details
Products / Brands
Prestige Consumer Healthcare
Thera Tears
Eye & Ear Care
Murine
Eye & Ear Care